Feedback

Prof. P Yogeeswari

Dean, Administration
Shri B.K. Birla and Smt. Sarala Birla Chair Professor
Senior Professor, Department of Pharmacy
Chairperson, Institutional Animal Ethics Committee

Alzheimer’s Disease, Anti-Cancer screening, Anti-inflammatory screening, Anticonvulsant screening, Autism spectrum disorder (ASD), Biophysical characterization, CNS Behavioral and cognition screening, Cancer, Dengue virus, Duchenne Muscular Dystrophy, Epilepsy, Fetal Alcohol spectrum disorder (FASD), Fragile X syndrome, Hepatitis C virus, Molecular pharmacology, Nerve conduction velocity, Neurochemical estimations in different regions of brain, Neuropathic pain including Diabetic neuropathy, Neuropathicpain, Neurotoxicity screening, Tuberculosis
Birla Institute of Technology and Science- Pilani, Hyderabad Campus Jawahar Nagar, Shameerpet Mandal, R.R. District, Pin-500078, INDIA

Papers in Conferences

  1. Yogeeswari, P, Therapeutic Strategies and Drugs under Investigations for Triple Negative Breast cancer. 2nd Indo Oncology Summit (CME Accredited), 15-17 November 2019, Bhubaneshwar, Orissa.
  2. Dusane A., Dwivedi S., Yogeeswari, P, In-house mGluR5 inhibitors as a therapeutic approach towards Autism: In-silica and in-vitro investigations. IBRO-APRC Associate School on Blood-Brain Barrier: From Basic Physiology to Neurological Disorders, 4-9 November 2019, Chandigarh, India.
  3. Yogeeswari, P, High Quality Sweet Lime juice powder compositions with enhanced real fruit content and stability for food, pharmaceutical and cosmetic applications. International Conference on Biotechnological Innovations in Food and Healthcare, 27-28 January 2019, Dubai.  (Best Presentation Award)
  4. Yogeeswari, P, Multiple crystal structure modeling in structure-based drug discovery: Case studies on successful diverse lead identification. 18th International Conference on Medicinal and Pharmaceutical Chemistry, 18-19 October 2018, Dubai. 
  5. Sawle, A., Gangadhar M., Yogeeswari, P, Pharmacological intervention to study the effect of antinocicpetive curcumin analogue in a rat model of migraine. International Society for Neurochemistry-ESN meeting, 20-24 August 2017, Paris, France. (Travel partially supported by BITSAA)
  6. Dwivedi, S., Medishetty, R., Kulkarni, P., Yogeeswari, P, Zebrafish larvae model: A novel approach to study Autism. International Society for Neurochemistry-ESN meeting, 20-24 August 2017, Paris, France. (Travel supported by DST)
  7. Gangadhar, M., Isava, O., Yogeeswari, P, Antiinflammatory compound with SIPSC blocking potential: A promising therapeutic approach for neurological pain disorders. International Society for Neurochemistry-ESN meeting, 20-24 August 2017, Paris, France.
  8. Yogeeswari, P, Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple negative and triple positice breast cancers. Keystone Symposium on Cancer Immunology and Immunotherapy: Taking place a mainstream oncology (C7-2017), 19-23 March 2017, Whistler, British Columbia, Canada. Accepted with BILL AND MELINDA GATES FOUNDATION GLOBAL HEALTH TRAVEL AWARD.
  9. Dwivedi, S., Medishetty, R., Kulkarni, P., Sriram, D., Yogeeswari, P, Zebrafish Larva model: A novel approach to study Autism. 2nd International Brain Research Organization (IBRO)/APRC Chandigarh School of Neuroscience, 14-22 December 2016, Chandigarh, India. WON THE THIRD BEST ORAL PRESENTATION AWARD.
  10. Sawale, A., Martharasala, G., Sriram, D., Yogeeswari, P, Screening studies of new chemical entities to evaluate their efficacy on rat model of migraine. 68th Indian Pharmaceutical Congress,  16-18 December 2016, Vishakapatnam, India. 
  11. Soni, V., Suryadevaraya, P., Samala, G., Singh, A., Yogeeswari, P, , Sriram, D., Nandicoori, V.K., Depletion of M. tuberculosis GlmU from infected murine lungs effects the clearance of the pathogen. BioAsia 2016, 8-10 February 2016, Hyderabad, India
  12. Shubham, D., Alokam, R., Srikanth, R., Piyush, B., Sriram, D, Yogeeswari, P,  Targeting orphan nuclear receptor RORA as a therapeutic option for Autism Spectrum Disorder. International Conference on "Cutting edge Pharmacology: Contemporary Issues and Future Challenges" & 48th Annual Conference of Indian Pharmacological Society, 18-20 December 2015, Rajkot, Gujarat. 
  13. Brahmam, M., Bobesh, K.A., Mikila, M., Reshma, S.L., Sriram, D, Yogeeswari, P, Development of 1,2,3-triazolo quinoline hybrid analogues as mycobacterial DNA gyrase inhibitors. Conference on Drug Discovery and Development : Global scenario-Indian Perspective, 20-21 November 2015, NIPER, Hyderabad.
  14. Reshma, S.R., Shalini, S., Yogeeswari, P, Sriram, D., Development of quinoline derivatives as potent Mtb lysine aminotransferase inhibitors targeting latent tuberculosis. Conference on Drug Discovery and Development : Global scenario-Indian Perspective, 20-21 November 2015, NIPER, Hyderabad.
  15. Bobesh, K.A., Reshma, S.R., Nikhila, M., Yogeeswari, P, Sriram, D., N-Benzyl-3,3-dimethoxyhexahydro-2H-furo[3,2-b]pyrrol-6-yl) methanesulfonamides as mycobacterial DNA gyrase inhibitors. Conference on Drug Discovery and Development : Global scenario-Indian Perspective, 20-21 November 2015, NIPER, Hyderabad.
  16. Srikanth, R., Alokam, R., Gangadhar, M., Susruth, J., Sriram, D, Yogeeswari, P, Design, Synthesis and Pharmacological evaluation of novel 1,3,5-triazine-2,4,6-triamine derivatives as potent and selective A2A adenosine receptor antagonists in the treatment of epilepsy. 7th Asian Association of Schools of Pharmacy (AASP) Conference, 30 October-2 November 2015, Taipei, Taiwan. 
  17. Hasitha, S.A., Battu, M.B., Yogeeswari, P.; Sriram, D. Identification of novel non-peptidic inhibitors for Cathepsin K in treatment of breast cancer bone metastasis: Pharmacophore-based 3D QSAR, molecular docking and biological evaluation. Gordon Research Conferences: Computer Aided Drug Design, 19-24 September 2015, Mount Snow in West Dover, VT, USA. 
  18. Srilakshmi, R.R., Sridevi, J.P., Yogeeswari, P.,  Sriram, D. Design, Synthesis and Biological evaluation of Benzothiazole derivatives as Mtb Lysine aminotransferase Inhibitors. National Conference on Drug Discovery and Development in Chemistry- Applications in Pharma Industry (DDDC-2015), 14-15 September 2015, Tirupati, India. 
  19. Brahmam, M., Renuka, J., Sridevi, J.P., Yogeeswari, P.,  Sriram, D. Development of novel quinolone p-phenylenediamine hybrid analogues mycobacterial DNA gyrase inhibitors to improve the cardio safety profile. National Conference on Drug Discovery and Development in Chemistry- Applications in Pharma Industry (DDDC-2015), 14-15 September 2015, Tirupati, India. 
  20. Bobesh, K.A., Renuka, J., Sridevi, J.P., Yogeeswari, P.,  Sriram, D. Substitution of the N-linked aminopiperidine class with piperazine moiety to the mycobacterial gyrase domain to reduce the hERG toxicity profile. National Conference on Drug Discovery and Development in Chemistry- Applications in Pharma Industry (DDDC-2015), 14-15 September 2015, Tirupati, India. 
  21. Gangadhar, M., Alokam, R., Sriram, D, Yogeeswari, P, MG2, a novel semicarbazone derivative, reduces neuropathic pain by inhibiting the expression levels of neuroinflammatory mediators. 2015 Keystone Symposia: C8: Pathways of Neurodevelopmental Disoders, 16-20 March 2015, California, USA.
  22. Gaus, A., Mishra, R.K., Alokam, R., Singhal, S.M., Sriram, D., Yogeeswari, P., Evaluation of 2,6-diaminopyrimidines as novel Rho kinase inhibitors using animal models of treatment of neurological disorders. 66th Indian Pharmaceutical Congress: India- Pharmacy of the World, 23-25 January 2015, Hyderabad, India. 
  23. Priyanka, P.; Aruna, M.; Banumurthy, N.L.; Yogeeswari, P.; Sriram, D. Effect of feature selection on Kinase Classification Models. International Conference on Computational Intelligence: Health and Diseases (CIHD), 27-28 December 2014, Vishakapatnam, India. 
  24. Priyanka, P., Reshma, A., Aruna, M., Yogeeswari, P., Sriram, D., Comparative modeling combined with Molecular dynamics and Docking studies to identify potent inhibitors of PKMzeta and Biological evaluation. 9th Brain Research Conference: Neuroprotection: Basic mechanism and translational potential, 13-14th November 2014, Washington DC, USA. 
  25. Ganesh, S.; Radhika, N.; Devi, P.B.; Yogeeswari, P.; Sriram, D. Design, synthesis and biological evaluation of 6-methylimidazo[2,1-b]thiazole-5-carboxylic acid derivatives as novel Mycobacterium tuberculosis pantothenate synthase inhibitors. 15th Tetrahedron Symposium- Asian Edition: Challenges in Bioorganic and Organic Medicinal Chemistry, 28-31 October 2014, Singapore. 
  26. Srikant, B., Methuku, S., Tharun, K.G., Shewta, M., Sridevi, J.P., Yogeeswari, P., Sriram, D.,  Chakraborti, A.K., Alpha-Sulphonamidophosphonates and bis alpha-aminophosphonates: New leads towards infectious disease chemotherapy. 248th ACS National Meeting & Exposition, 10-14 August, San Francisco, CA, USA.
  27. Renuka, J., JeanKumar, V., Bobesh, A., Vijay, S., Devi, P.B., Venkat, K.P., Priyanka, S., Keerthana, S., Pushkar, K., Yogeeswari, P., Sriram, D., Design and biological evaluation of novel antibacterial inhibitors against DNA GyrB from clinical isolates of Staphylococcus aureusGordon Research Conferences, 10-15th August 2014, Maine, USA.
  28. Srikanth, R., Reshma, A., Kulkarni, P., Sriram, D., Yogeeswari, P., Structure-based drug design, synthesis and screening of Adenosine A2A antagonists as novel antiepileptic agents. 11th European Congress on Epileptology, 29th June-3rd July 2014, Stockholm, Sweden
  29. Kakan, S.K., JeanKumar, V.U., Devi, P.B., Shalini, S., Sriram, D., Yogeeswari, P., Targeting Mycobacterium tuberculosis Lysine aminotransferase: Design, synthesis and in vitro evaluation of small molecule compounds. International Conference on "Drugs for the Future: Infectious Diseases", Antimicrobial Drug Discovery: Challenges and Perspectives, 27-28 March 2014, NIPER, Hyderabad, India. (WON THE BEST PAPER IN POSTER SECTION)
  30. Shravan, M, Renuka, J., Yogeeswari, P., Sriram, D., Design and biological evaluation of novel Staphylococcus aureus DNA gyrase inhibitors. International Conference on "Drugs for the Future: Infectious Diseases", Antimicrobial Drug Discovery: Challenges and Perspectives, 27-28 March 2014, NIPER, Hyderabad, India.
  31. Devi, P.B., Saxena, S., Sriram, D., Yogeeswari, P., Screening and Identification of Potent Inhibitors against pantothenate synthetase- An important target Mycobacterium tuberculosis infection. 3rd ScienceOne Conference on Drug Discovery and Development (SCDDD), 21-23 January 2014, Dubai.
  32. Yogeeswari, P.,  Patrisha J.T., Sriram, D., Structure-based drug design utilizing multiple crystal structures to design anti-viral agents, 3rd ScienceOne Conference on Drug Discovery and Development (SCDDD), 21-23 January 2014, Dubai.
  33. Mishra R.K., Matharasala G., Srivastav G., Singhal S.M., Sriram, D., Yogeeswari, P., Evaluation of antinociceptive properties of novel Rho Kinase inhibitors using animal models of neuropathic pain, 46th Annual Congress of the Indian Pharmacological Society IPSCON-2013, 16-18th December 2013, Bangalore, India.
  34. Matharasala G., Mishra R.K., Srivastav G., Singhal S.M., Sriram, D., Yogeeswari, P., Novel semicarbazone derivatives effective against Diabetic peripheral neuropathy, 46th Annual Congress of the Indian Pharmacological Society IPSCON-2013, 16-18th December 2013, Bangalore, India.
  35. Saketh, S.D., Reshma, A., Srikant, V., Sriram, D., Yogeeswari, P., BIA-6: A novel AKT inhibitor with potent activity in lung cancer, 15th World Conference on Lung Cancer, 27-30 October 2013, Sydney, Australia. 
  36. Madhu Babu, B., D. Sriram, P. YogeeswariTargeting microglial cathspsin S to treat neuropathic pain: Drug design and biological evaluation, 8th Congress of the European Federation of IASP Chapters- Pain in Europe VIII, 9-12 October 2013, Florence, Italy. 
  37. P. YogeeswariR.K. Mishra, A. Semwal, D. Sriram,  Evaluation of antinociceptive properties of novel curcumin derivatives using animal models of neuropathic pain, 5th ASEAPS (Association of South-East Asian Pain Societies Conference), Pain: The Unseen Disease, 2nd-5th May 2013, Singapore.
  38. J. T. Patrisha, D. Sriram, P. YogeeswariDiscovery of novel small molecule inhibitors of Human immunodeficiency virus (HIV) protease: Pharmacophore modeling, 3D QSAR studies and High-throughput screening, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  39. B. K. Andrews, V.U. Jean Kumar, J. Renuka, P. Yogeeswari, D. Sriram, Discovery of novel benzimidazole class of antibacterial agents targeting the ATPase domains of DNA gyrase, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  40. A.T. Dharmaraja, A. Mallika, D. Sriram, P. Yogeeswari, H. Chakrapani, Small molecule reactive oxygen species generator as antimycobacterial agents, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  41. M. Siddharth Sai, V.U. Jean Kumar, A. Reshma, P. Yogeeswari, D. Sriram, In-Silico design, Synthesis and in-vitro screening of novel inhibitors of Chorismate mutase enzyme involved in Shikimate pathway of Mycobacterium tuberculosis, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  42. P. Ganesh, V.U. Jean Kumar, P. Sridevi, P. YogeeswariD. Sriram, Development of novel substituted benzoxazolinone derivatives as potential antitubercular agents, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  43. M. Brahmam, J. Renuka, V.U. Jean Kumar, P. YogeeswariD. Sriram, In-Silico discovery of novel phenylenediamine class of antibacterials as potential DNA gyrase inhibitors, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  44. P. Santosh, V.U. Jean Kumar, A. Reshma, D. Sriram, P. YogeeswariDevelopment of carvacrol derivatives as potential inhibitors of MTB chorismate mutase, 2nd UK-India MedChem Congress, 22-23 March 2013, Hyderabad.
  45. S. Sahithi, J. Renuka, P. Yogeeswari, D. Sriram, In-Silico Design and in-vitro assay of inhibitors of pathogenic Staphylcoccus aureus DNA gyrase, 5th International Symposium of Drug development for Orphan/Neglected Diseases, 26-28 February 2013, Lucknow.
  46. P. Santosh, V.U. Jean Kumar, S. Saxena, P. Yogeeswari, D. Sriram, In-Silico Design and Synthesis of Novel Nitrothiazole derivatives as potential inhibitors of MTB CysK1, 5th International Symposium of Drug development for Orphan/Neglected Diseases, 26-28 February 2013, Lucknow.
  47. A.Seal, P. Yogeeswari, D. Sriram, D.J. Wild, OSDD Consortium, 3D Virtual Screening of PknB inhibitors using data fusion methods, 1st Official Conference of the International Chemical Biology Society, 4-5 October, 2014CambridgeMA, USA
  48. P. Yogeeswari, A.S.K. Reddy, J.V. Ragavendran, Arvind Semwal, Ram Kumar Mishra, D. Sriram, Spironucleus linked GABA analogues as potential antiepileptic agents acting through GABA mediation and inhibiting nitric oxide and free radicals,  10th European Congress on Epileptology30th Septemeber -4th October 2012, London, United Kingdom. 
  49. Ram Kumar Mishra, Reshma Chowdary,  D. Sriram,  P. YogeeswariDesign of Novel Rho Kinase Inhibitors for the treatment of Diabetic Complications  using Energy-based Pharmacophore Modelling, In-silico screening and Docking studies,  3rd World Congress on Diabetes & Metabolism,24-26 Septemeber 2012, Hyderabad, India.  
  50. P. Sripriya, M. Soumya, Reshma Alokam, P. Susruta,  D. Sriram,  P. YogeeswariStructure Guided Design of Inhibitors for SH3 domain of p47phox subunit of NADPH Oxidase 2 implicated in various human disorders,  3rd World Congress on Diabetes & Metabolism,24-26 Septemeber 2012, Hyderabad, India.  
  51. M. Saketh,  Ram Kumar Mishra, D. Sriram,  P. Yogeeswari Design of Novel Protein Kinase Inhibitors for the treatment of Painful Diabetic Neuropathy using  Energy-based Pharmacophore Modelling and Docking studies,  3rd World Congress on Diabetes & Metabolism,24-26 Septemeber 2012, Hyderabad, India. 
  52. A. Mallika, Shubmitha Bhatnagar, A. Ravi, V.U. Jean Kumar, T.H. Manjashetty,   P. Yogeeswari,  D. Sriram, Novel acridinone derivatives: Design, synthesis, SIRT1 enzyme and tumour cell growth inhibition studies,  3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India.  
  53. Reshma Alokam, Jean Kumar,  D. Sriram,  P. YogeeswariIdentification of novel inhibitors of Chorismate mutase enzyme involved in Shikimic pathway of Mycobacterium tuberculosis: Design and In-vitro screening, 3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India.  
  54. P. Venkat Koushik,  P. Yogeeswari,  D. Sriram, Designing Small Molecule Inhibitors of NMPRTase as Anticancer leads using in silico approach, 3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India. 
  55. J.T. Patrisha, K. Sridevi, K. Shruti,  D. Sriram,  P. YogeeswariDiscovery of New Small Molecule Inhibitors of Hepatitis C Virus RNA-dependent RNA polymerase: Pharmacophore modelling, 3D-QSAR studies and High-throughput screening,  3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India.  
  56. Madhu Babu, B., Madhuri Chandra, D. Sriram,  P. YogeeswariDiscovery of New Microglial Cathepsin S Inhibitors for the Treatment of Neuropathic Pain: Pharmacophore modelling, 3D-QSAR and High-throughput screening, 3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India. 
  57. Devi, P.B., Mallika A.,  P. Yogeeswari, D. Sriram, Development of Pantothenate Synthetase Inhibitors for Mycobacterium Tuberculosis Infection: Design and Enzyme Inhibition,  3rd World Congress on Biotechnology,13-15 Septemeber 2012, Hyderabad, India.  
  58. Jean Kumar V.U, Manoj C., Vijay Soni, Patrisha J.T., Mallika A., Yogeeswari P., Nandicoori, V.K., Sriram D., Discovery of novel Mycobacterium tuberculosis GlmU inbibitors, 16th Annual Conference of the Swedish Structural Biology Network, 15-18 June 2012, Talberg, Sweden.
  59. Omer Poyraz, Robert Schnell, Jean Kumar V.U., Yogeeswari P., Sriram D., Gunter Schneider, Discovery of inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (OASS) CysK1 as potential agents against mycobacterial latency. 16th Annual Conference of the Swedish Structural Biology Network, 15-18 June 2012, Talberg, Sweden.
  60. P. Ravichand, Ramakrishna Vadrevu, P. Yogeeswari, D. Sriram, Structure-based Pharmacophore Modeling and Virtual screening of β-secretase Inhibitors, International Conference on Advances in Biological Sciences, 15-17 March 2012, Kannur, Kerala, India. 
  61. Monika Sharma, Arvind Semwal, V. Deekshith, D. Sriram, P. Yogeeswari, Discovery of newer triazolo[3,4-b]thiadiazoles for the treatment of neuropathic pain: Pharmacophoric hybrid approach for multifunctional lead development, 4th International Conference on Drug Discovery & Therapy, 12-15 February  2012, Dubai, UAE.
  62. A. Ravi Kiran, D. Sriram, P. Yogeeswari, Prediction of bioactivity and toxicity of BITS Database compounds using empirical and focused scoring techniques,  63rd Indian Pharmaceutical Congress 2011, 19-21 December 2011, Bangalore, India.(WON THE BEST PAPER IN PODIUM SECTION)
  63. A. Monika, A.V. Ramani, V.U. Jean Kumar, H.M. Thimmappa, P. Yogeeswari, D. Sriram, One pot synthesis of novel substituted 1,3-thiazinylisonicotinamides, in-vitro evaluation and pre-pharmacokinetic profile studies for the treatment of tuberculosis, 63rd Indian Pharmaceutical Congress 2011, 19-21 December 2011, Bangalore, India. (WON THE SECOND BEST PAPER AWARD IN POSTER SECTION)   
  64. M. Siddarth Sai, A. Mallika, V.U. Jean Kumar, P. Yogeeswari, D. Sriram, In-silico design and synthesis of small molecule inhibitors of human SIRT1, 63rd Indian Pharmaceutical Congress 2011, 19-21 December 2011, Bangalore, India. 
  65. V. Mahesh Kumar, Sunil Kumar Sharma, V.U. Jean Kumar, P. Yogeeswari, D. Sriram, Design, Synthesis and in-vitro evaluation of novel imidazo-quinaxolone derivatives as potential anti-tubercular drugs, 63rd Indian Pharmaceutical Congress 2011, 19-21 December 2011, Bangalore, India.
  66. Sunil Kumar Sharma, V. Mahesh Kumar, V.U. Jean Kumar, P. Yogeeswari, D. Sriram, Design, Synthesis and in-vitro evaluation of novel 4-aminopiperido-thiazole derivatives as potential antitubercular agents, 63rd Indian Pharmaceutical Congress 2011, 19-21 December 2011, Bangalore, India.  
  67. Yukti Singh, Monika Sharma, D. Sriram, P. Yogeeswari, Neurotoxicological evaluation of BITS candidate drugs in four animals models,  XXXXIVth Annual Conference of Indian Pharmacological Society, 19-21 December 2011, Manipal, India.
  68. V. Deekshith, Monika Sharma, D. Sriram, P. Yogeeswari, Evaluation of analgesic activity of new chemical entities in two rodent models of pain, XXXXIVth Annual Conference of Indian Pharmacological Society, 19-21 December 2011, Manipal, India.
  69. M. Gangadhar, Monika Sharma, D. Sriram, P. Yogeeswari, Preclinical evaluation of some novel heterocycles against postoperative pain, XXXXIVth Annual Conference of Indian Pharmacological Society, 19-21 December 2011, Manipal, India.
  70. Monika Sharma, M. Ganghadhar, Binita Kundu, Arvind Semwal, D. Sriram, P. Yogeeswari, Pharmacological profiling of triazolone derivatives as new leads for neuropathic pain treatment, XXXXIVth Annual Conference of Indian Pharmacological Society, 19-21 December 2011, Manipal, India.
  71. Siddarth Sai, M., Jean Kumar, P. Yogeeswari, D. Sriram, Design, synthesis and in-vitro evaluation of novel piperido-hydrazine derivatives as potential anti-tubercular agents, MedChem-2011 Conference on Anti-infective drug Discovery & Development, 28-29th October 2011, Indian Institute of Technology, Chennai, India.(WON THE BEST PAPER IN POSTER SECTION)  
  72. P. Yogeeswari, A.Sunil Kumar Reddy, Arvind Semwal, M. Arjun, D. Sriram, Multifunctional drug lead discovery for the treatment of neuropathic pain including trigeminal neuralgia and diabetic neuropathy: Combination of GABA receptor, cannabinoid receptor and nitric oxide as targets, 14th Asian Chemical Congress, 5-8 Septemeber 2011, Bangkok, Thailand.
  73. Jean Kumar, Thimmappa H.M., Pritesh Bhatt, Srividya M., P. Yogeeswari, D. Sriram, In-silico design and synthesis of novel 2-(1-aminocyclobutyl)-2-hydroxy acetic acid as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase, RSC MedChem-2011, 25-26th February 2011, Indian Institute of Chemical Technology, Hyderabad, India.
  74. Thimmappa H.M., P. Yogeeswari, D. Sriram, Synthesis and evaluation of isonicotinoylpyrazolopiperidine derivatives for the treatment of tuberculosis, RSC MedChem-2011, 25-26th February 2011, Indian Institute of Chemical Technology, Hyderabad, India.
  75. Monika A., Thimmappa H.M., P. Yogeeswari, D. Sriram, Dicyclohexylcarbodiimide mediated one pot synthesis of novel substituted 1,3- thiazinylisonicotinamides and evaluation for the treatment of tuberculosis, RSC MedChem-2011, 25-26th February 2011, Indian Institute of Chemical Technology, Hyderabad, India.
  76. Mallika A., Ravikiran A., P. Yogeeswari, D. Sriram, Development of homology model and docking studies of Mycobacterium tuberculosis sirtuin protein (Rv1151c), RSC MedChem-2011, 25-26th February 2011, Indian Institute of Chemical Technology, Hyderabad, India.
  77. P. Yogeeswari, A. Sunil Kumar Reddy, A. Semwal, D. Sriram, Novel role of GABAergic anticonvulsant compounds in alleivating neuropathic pain in two animal models, 43rd Annual Conference of Indian Pharmacological Society & International Conference on Pharmacology & Translational Research & ICMR Centenary Year Celebrations, 13-16th December 2010, NIN, Hyderabad, India.
  78. Monika Sharma, A. Sunil Kumar Reddy, A. Semwal, D. Sriram, P. Yogeeswari, Effectiveness of Newer Lipophilic GABA analogues against epilepsy, 43rd Annual Conference of Indian Pharmacological Society & International Conference on Pharmacology & Translational Research & ICMR Centenary Year Celebrations, 13-16th December 2010, NIN, Hyderabad, India.
  79. P. Yogeeswari, M. Arjun, A. Semwal, R. Thirumurugan, D. Sriram, Novel role of GABAergic Anticonvulsant Compounds in allievating neuropathic pain like behaviour in rodent models of incisional pain by inhibiting nitric oxide, 24th Annual Conference of Indian Society of Pain, 6-8 February 2009, Hyderabad, India.
  80.  P. Senthil Kumar, M. Dinakaran, P. Yogeeswari, D. Sriram, A. China, V. Nagaraja, Synthesis and antimycobacterial activities of novel 6-nitoquinolones-3-carboxylic acid, 59 th Indian Pharmaceutical Congress,20-23rd December 2007, Varanasi, India.
  81.  A. Sunil Kumar Reddy,  D. Sriram, V. Ranganadh, P. Yogeeswari, Synthesis  of newer N-spiro substituted GABA derivatives as anticonvulsants, 59th Indian Pharmaceutical Congress,20-23rd December 2007, Varanasi, India.
  82.  Meena K. Purohit, Niloufer M, P. Senthil Kumar, P. Yogeeswari, D. Sriram, A facile microwave-assisted synthesis of novel 3,5-dinitrosalicylamides and their antimycobacterial activity, 59th Indian Pharmaceutical Congress,20-23rd December 2007, Varanasi, India.
  83. Niloufer M, Meena K. Purohit, P. Senthil Kumar, J. Vaigunda Ragavendran, M. Arjun, D. Sriram, P. Yogeeswari,  Synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl)furoic 2-acid hydrazones in two in-vivo models of neuropathic pain, 59th Indian Pharmaceutical Congress,20-23rd December 2007, Varanasi, India.
  84. D. Sriram, M. Dinakaran, R.V. Devakaram, P. Yogeeswari, Synthesis and antimalarial activity of aromatic amino analogues of artemisinin, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  85. A.S.K. Reddy, Y. Nageswari, S.K. Patel, D. Sriram, P. Yogeeswari, Newer GABA analogs as CNS agents: Synthetic integration of GABA in 1,2,4-triazol-2H-3-one, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  86. P. Senthil kumar, M. Dinakaran, P. Yogeeswari, D. Sriram, Synthesis and in vitro antimycobacterial activity of some novel fluoroquinolones, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  87. J.V. Ragavendran, I. Vikram Reddy, P. Yogeeswari, D. Sriram, Synthesis of 4-{[(3Z)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]amino}-N-substituted phenyl) butanamides possessing antiallodynic and antihyperalgersic activities in two rat models of neuropathic pain, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  88. D. Banerjee, T.R. Bal, P. Yogeeswari, D. Sriram, L. Sebastin, A. Desai, S.N. Madhusudhana, V. Ravi, Isatin derivatives inhibit Japanese encephalitis virus entry and replication in-vitro, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  89. P. Senthil Kumar, M. Dinakaran, P. Yogeeswari, D. Sriram, Synthesis and antitubercular activities of 1-(cyclopropyl/t-butyl/4-fluorophenyl)-1,4-dihydro-6-nitro-4-oxo-7-(substituted secondary amines)-1,8-naphthyridine-3-carboxylic acid, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  90. A.S.K. Reddy,  J.V. Ragavendran, P. Yogeeswari, D. Sriram, Pharmacological screening of candidate anticonvulsants in the animal model of febrile seizures, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  91. K.N. Purna, P. Dhakla, P. Senthil Kumar, P. Yogeeswari, D. Sriram, 5-Nitro-2-furaldehyde thiosemicarbazones: Synthesis and in-vitro antimycobacterial activities, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  92. M. Dinakaran, C. Yogesh, P. Yogeeswari, D. Sriram, Synthesis of various 7-substituted-1-t-butyl-1,4-dihydro-8-methyl-6-nitro-4-oxo quiniline-3-carboxylic acid, 3rd International Symposium on Current Trends In Drug Discovery Research CTDDR - 2007, 17 - 21st February 2007, Chandigarh, India.
  93. P. Yogeeswari, Synthesis of 4-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)N-(substitutedphenyl)butanamides possessing antiallodynic and antihyperalgesic activities in two rat models of neuropathic pain, 11th APTI National Convention, 1-3 September, 2006, Bangalore, India (WON THE BEST PAPER IN PODIUM SECTION)
  94. P. Yogeeswari, R. Kavya, V. Reddy, D. Sriram, Newer approaches in the design of Anticonvulsants effective in hyperthermia-induced febrile seizures, 6th Asian & Oceanian Epilepsy Congress, 16-19th Novemeber 2006, Kuala Lumpur, Malaysia.
  95. D. Sriram, S. Mehta, Discovery of lesser neurotoxic and effective anticonvulsant agents active in four animal models of seizure, 6th Asian & Oceanian Epilepsy Congress, 16-19th Novemeber 2006, Kuala Lumpur, Malaysia.
  96. V. Ragavendran, R. Kumar, P. Yogeeswari, Design of GABA uptake inhibitors: Synthesis and anticonvulsant properties, 6th Asian & Oceanian Epilepsy Congress, 16-19th Novemeber 2006, Kuala Lumpur, Malaysia.
  97. D. Sriram, M. Dinakaran, R.V. Devakaram, P. Yogeeswari, Synthesis and antimalarial activity of aromatic amino analogues of artemisinin, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  98. A.S.K. Reddy, Y. Nageswari, S.K. Patel, D. Sriram, P. Yogeeswari, Newer GABA analogs as CNS agents: Synthetic integration of GABA in 1,2,4-triazol-2H-3-one, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  99. P. Senthil kumar, M. Dinakaran, P. Yogeeswari, D. Sriram, Synthesis and in vitro antimycobacterial activity of some novel fluoroquinolones, 58th Indian Pharmaceutical Congress, 1-3rd December 2006, Mumbai, India.
  100. Rohit Nelli, P. Senthil Kumar, P. Yogeeswari, D. Sriram, Microwave-assisted synthesis of some novel 2-[3-(4-bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl]-N-substituted amides, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  101. V. Ranganadh, P. Roheeth Kumar, M. Mallika, P. Yogeeswari, D. Sriram, Synthesis of copper complexes of thiosemicarbazones as antitumour agents, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  102. J.V. Ragavendran, R. Kavya, S.K. Patel, D. Sriram, P. Yogeeswari, Design and synthesis of 4-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)amino] butanmaides as 4-aminobutyric acid (GABA) mimetics,  National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  103. Y. Nageswari, P. Sahithya, J.V. Ragavendran, D. Sriram, P. Yogeeswari, Synthesis and anticonvulsant evaluation of 2,6-dimethylphenylaminoacetylamino butanamides, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  104. M. Mallika, P. Yogeeswari, D. Sriram, Design and synthesis of gold (III) and platinum (III) complexes of aryl-substituted semicarbazones as antitumour agents, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  105. Jatinder Kaur, Simarjeet Kaur, P. Yogeeswari, D. Sriram, Pharmacophore modeling of COX-2 inhibitors, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  106.  Debjani Banerjee, M. Dinakaran, P. Senthil Kumar, R.V. Devakaram, P. Yogeeswari, D. Sriram, Synthesis and Antibacterial evaluation of Phenothiazine derivatives, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  107. Bhargava, P. Senthil Kumar, P. Yogeeswari, D. Sriram, Synthesis of certain 7-substituted fluoroquinolones, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, 7-8th April, 2006, Pilani, India.
  108. Y. Nageswari, J.V. Ragavendran, D. Sriram, P. Yogeeswari, Design and Synthesis of 4-(1,3-Dioxoisoindolin-2-yl)butane hydrazones as anticonvulsant pharmacophoric hybrids, 2nd International Symposium on Drug Discovery & Process Research, 10-12th Feb, 2006, Belgaum, India.
  109. J.V. Ragavendran, S.K. Patel, D. Sriram, P. Yogeeswari, Design and Synthesis of Newer amino derivatives of 4-aminobutyric acid as anticonvulsants, 2nd International Symposium on Drug Discovery & Process Research, 10-12th Feb, 2006, Belgaum, India.
  110. R. Kavya, J.V. Ragavendran, D. Sriram, P. Yogeeswari, Pharmacological evaluation of the analgesic efficacy of candidate anticonvulsant compounds in neuropathic pain models, 2nd International Symposium on Drug Discovery & Process Research, 10-12th Feb, 2006, Belgaum, India.
  111. M. Shalini, J.V. Ragavendran, P.R. Kumar, D. Sriram, P. Yogeeswari, Quantum mechanical modeling of aryl semicarbazones as anticonvulsants, 2nd International Symposium on Drug Discovery & Process Research, 10-12th Feb, 2006, Belgaum, India.
  112. P. Yogeeswari, J.V. Ragavendran, Animal models of seizures, '6th EMBL International Predoc Symposium "Animal Models - Tips and Tricks from Nature", 11-13th May 2005, Rome, Italy.
  113. P. Yogeeswari, Drug design based on Molecular hybridization and integration, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  114. D. Sriram, T.R. Bal, P. Yogeeswari, Aminopyrimidinimino isatin analogues: Design and synthesis of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad spectrum Antimicrobial properties, National Symposium on Futiritic trends in Pharmacotherapeutics and formulation development, Banaras Hindu University, Varanasi, March 4-5th, 2005.
  115. P. Yogeeswari, D. Sriram, P. Roheeth Kumar, Development of Anticonvulsant leads by integrating structure-based drug design and database screening, National Symposium on Futiritic trends in Pharmacotherapeutics and formulation development, Banaras Hindu University, Varanasi, March 4-5th, 2005.
  116. R.V. Devakaram, N.S. Myneedu, P. Yogeeswari, D. Sriram, Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  117. P.R. kumar, G.A. Nilkanth, P. Yogeeswari, Rational approach for the design of a central nervous system active chemical library, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb 2005, BITS, Pilani, India.
  118. K. Srikanth, V. Ranganadh, D.R.K. Vyas, B. Murali Krishna, P. Yogeeswari, D. Sriram, Design of anticonvulsant drug database, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  119. V.N.R. Pavan Kumar, P. Yogeeswari, D. Sriram, T.R. Bal, QSAR studies on Non-Nucleoside reverse transcriptase inhibitors belonging to phenylethylthiazolylthiourea, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  120. P. Kudyar, P. Yogeeswari, M. Shalini, D. Sriram, Synthesis of 2,5-dimethylphenyl substituted semicarbazones as anticonvulsants, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  121. K. Purna Nagasree, P. Yogeeswari, D. Sriram, Newer isonicotinoyl hydrazones: Synthesis and in-vitro antimycobacterial activity, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  122. J. V. Ragavendran, P. Yogeeswari, R. Thirumurugan, D. Sriram, In-vitro and ex-vivo enzyme inhibition studies on some BITS anticonvulsant compounds, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  123. M. Shalini, P. Yogeeswari, D. Sriram, J. P. Stables, Synthesis of some 4,5-(substituted diphenyl)-2H-1,2,4-triazole-3(4H)-one derivatives and their anticonvulsant properties, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  124. R. Kavya, S. Tiwari, P. Yogeeswari, D. Sriram, Synthesis and in-vitro cytotoxicity evaluation of gatifloxacin Mannich bases, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  125. T.R. Bal, P. Yogeeswari, D. Sriram, Aminopyrimidinimino isatin analogues: Design and synthesis of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad spectrum Antimicrobial properties, International Symposium on Recent Advances in drug design and delivery systems, 26-27th Feb, 2005, BITS, Pilani, India.
  126. R. Kavya, R. Thirumurugan, D. Sriram, P. Yogeeswari; “Pharmacological Evaluation of aryl(heteroaryl) semi(thio)carbazones for CNS activity” 55th Indian Pharmaceutical congress, Chennai, December 19-21, 2003.
  127. J. Vaigunda Ragavendran, R. Thirumurugan, I. Sridharan, D. Sriram, P. Yogeeswari; “4-amino butyrate amino transferase (GABA-T) inhibition as a possible mechanism of some novel anticonvulsant aryl semicarbazones”, 55th Indian Pharmaceutical Congress, Chennai, December, 19-21, 2003.
  128. R. Thirumurugan, D. Sriram, P. Yogeeswari; “Design and synthesis of novel aryl semicarbazone derivatives as anticonvulsants with GABA and glycine mediated mechanism”, International symposium on drug discovery and process research, Shivaji University, Kolhapur, January 23-25, 2003.
  129. T. R. Bal, D. Sriram, P. Yogeeswari, Non-nucleoside reverse transcriptase inhibitors for the treatment of AIDS, International symposium on Emerging trends in Genomics and Proteomics education and research, BITS, Pilani, Jan 12-13th, 2003.
  130. K. Jyothi Mallika, R. Thirumurugan, N.S. Chakravarthy, P. Yogeeswari, D. Sriram; “Tetrahydro-2H-1,3,5-thiadiazine-5-(4-Pyridyl carboxamide)-2-thione derivatives as prodrugs for isoniazid : synthesis and Antituberculous Activity”, 54th Indian Pharmaceutical Congress, Pune, December, 13-15, 2002.
  131. I. Sridharan, B. Archana, R. Thirumurugan, P. Yogeeswari, D. Sriram; “γ-Aminobutyric acid (GABA) level studies on novel anticonvulsant compounds in rat brain tissue preparation”, 54th Indian Pharmaceutical Congress, Pune, December 13-15, 2002.

 

International Visits

  1. Dubai, UAE, BITS-Pilani, Dubai campus conference on Biotechnological Innovations in Food and Healthcare, January 2019.
  2. Kuala Lumpur, Malaysia - Entrepreneurship summit, December 2018.
  3. Dubai, UAE- Speaker at 18th International Conference on Medicinal and Pharmaceutical Chemistry held in October 2018
  4. Irvine, California, USA- Visited UCI Technology Business Centre for a Business Plan Competition in June 2017.
  5. Barcelona, Spain- Speaker at the 8th Annual Congress of Neurotalk-2017 in May 2017.
  6. Whistler, British Columbia, Canada-Presented research paper at the Keystone Symposia on Cancer Immunology and Immunotherapy in March 2017
  7. Lille and Paris, France- Research exchange visit to Pasteur Institute at Lille and Paris in April 2015.
  8. Buenos Aires, Argentina- To receive IASP2014 award for excellence in Pain research among the developing country scientists in October 2014.
  9. Dubai, UAE- To present a research paper on Antiviral drug design in the 3rd ScienceOne Conference on Drug Discovery & Development in Jan 2014.
  10. Kiev, Ukraine- Visited Bogomoletz Institute of Physiology and Institute of Organic Chemistry for a collaborative research visit in May 2013.
  11. Singapore- Presented a research paper on Neuropathic pain research in the 5th Association of South-East Asian Pain Societies Conference in May 2013.
  12. Durban, South Africa- Visited KwaZuluNatal University for collaborative research visit and K-RITH as invited speaker in February 2013.
  13. Belem, Brasil- Visited Federal University of Para on a collaborative research visit during September 2012.
  14. Stockholm, Sweden- Visited Karolinska Institute on a collaborative project visit during May 2012.
  15. Stockholm, Sweden- Visited Karolinska Institute on a collaborative project visit during October-November 2010.

 

International student exchanges and training

     1. Mr. Ahik Seal, Ph.D. student of Indiana University, Bloomington, USA was offered training in CADD lab for 3 months from June 2012-August 2012 under IUSSTF RISE program under the supervision of Prof. P. Yogeeswari and Prof. D. Sriram.
     2. Mr. Edikarlos, Ph.D. student of Federal University of Para, Brazil spent 2 months for research project training in Drug Synthesis during November 2012-December 2012 sponsored by IBSA project.
     3. Ms. Glacia Nascimoto, Ph.D. student of  Federal University of Para, Brazil spent 2 months for research project training in High-throughput cell assays during November 2012-December 2012 sponsored by IBSA project.
     4. Mr. Guilherme Peterson, Ph.D. student of  Instituto Nacional de Ciência e Tecnologia em Tuberculose, Brazil was on exchange fellowship under Science Without Borders for 6 months at our CADD and Drug screening lab from October 2013 till April 2014.
     5. Mr. Bomba Tatsinkou Francis Desire, Ph.D. student of University of Dschang, Cameroon was on exchange fellowship supported by NAM S&T Centre under the research training fellowship for developing countries scientist in our Neuropathic pain research lab from March 2014 till September 2014.
      6. Ms. Kenia Pissinate, Post Doc of Instituto Nacional de Ciencia e Technologia em Tuberculose, Brazil was on exchange fellowship under Science Without Borders for 2 months at our CADD and Drug synthesis labs under the supervision of Prof. Yogeeswari and Prof. Sriram from 1st Feb 2015 till 31st March 2015.
7. Ms. Mediesse Kengne Francine, Research Assistant, The Biotechnology Centre of Nkolbisson, University of Yaounde I Messa is being approved on  exchange fellowship supported by NAM S&T Centre under the research training fellowship for developing countries scientist in our Research lab from May 2015 till October 2015.

 

Research Collaborations

  • National Institute of Health, Bethesda, USA
  • National Cancer Institute, USA
  • National Institute of Mental Health and Neurosciences, Bangalore, India
  • Indian Institute of Science, Bangalore, India.
  • National Institute of Immunology, New Delhi, India
  • Karolinska Institute, Stockholm, Sweden
  • The University of Queensland, Australia
  • Department of Ophthalmology & Visual Science, University of Illinois, Chicago, USA
  • Dongduk Women's University, Seoul, Korea
  • Pasteur Institute, University of Lille, France
  • University of KwaZulu Natal, Durban, South Africa
  • Federal University of Para, Belem, Brazil
  • Bogomoletz Institute of Physiology National Academy of Science, Ukraine
  • Faculty of Medicine of Porto, Porto, Portugal
  • Instituto Nacional de Ciencia e Technologia em Tuberculosis, MCT/CNPq, Porto Alegre, Brazil
  • Incozen Therapeutics Pvt. Ltd, Hyderabad 
  • Rutger's The State University of New Jersey, New Jersey Medical School, Newark, New Jersey, USA
  • Basavatarakam Indo-US Cancer Hospital, Hyderabad, India
  • Army College of Dental Sciences, Hyderabad